معرفی
Prof. Dr. Yavuz KARABAĞ is a distinguished academic and medical professional at Kafkas University Faculty of Medicine, Department of Internal Medical Sciences, specializing in Cardiology. With extensive experience in clinical cardiology and research, he has established himself as a leading figure in cardiovascular medicine, particularly in areas related to myocardial infarction, hypertension, and electrocardiographic analysis.
Dr. Karabağ completed his Medical Specialization in Cardiology at Kafkas University, Faculty of Medicine, Department of Cardiology in 2014, following his Bachelor's Degree in Medicine from Atatürk University Faculty of Medicine, which he completed in 2009. His doctoral thesis focused on 'Evaluation of right ventricular deformation parameters in COPD patients.'
His research interests span multiple critical areas in cardiology including coronary artery disease, myocardial infarction, hypertension, electrocardiography, and echocardiography. He has made significant contributions to understanding the relationship between inflammatory markers and cardiovascular outcomes, particularly focusing on C-reactive protein to albumin ratio, systemic immune-inflammation index, and other biomarkers in predicting outcomes in various cardiac conditions.
An analysis of his recent publications reveals a strong emphasis on the intersection of inflammation markers and cardiovascular outcomes. His work frequently examines how biomarkers like CRP/albumin ratio, HALP score, and systemic immune-inflammation index correlate with mortality, complications, and treatment outcomes in conditions ranging from ST-elevation myocardial infarction to hypertension and pulmonary embolism. His research also explores novel electrocardiographic parameters for predicting cardiac events and understanding circadian blood pressure patterns.
Dr. Karabağ has been actively involved in numerous research projects, including a Higher Education Institutions Supported Scientific Research Project from 2019-2022 titled 'Markers of Renal Damage (Podocalyxin and Neutrophil Gelatinase-Associated Lipocalin (NGAL)) Levels Before and After Contrast Media Administration in Patients Scheduled for Angiography in the Coronary Intensive Care Unit.'
